Loading...
PMLive.jpg)
08-Oct-14 With rising economic prosperity and the ageing population Turkey’s government has been systematically increasing healthcare infrastructure. Turkey has traditionally focused on generics, but more recently the industry has shifted towards a more intensive focus on R&D. (Image: PMLiVE)
Read MoreRia Novosti and Larisa Sayenko.jpg)
23-Sep-14 Pharma companies in Russia will be able to produce the bulk of vital and essential drugs needed in the country within two or three years, Deputy Industry & Trade Minister Sergei Tsyb has said. Drug production in Russia has doubled since 2010. [image: RIA Novosti and Larisa Sayenko]
Read More
Service example: Standardised demographics and epidemiology databases covering 75 countries, China’s 31 provinces and 2,263 counties, and India’s 32 states and 59 key cities, with 20 year forecasts – allowing drug and vaccine companies to understand tomorrow’s disease burden and the health expenditure environment.